We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
301
GE Aerospace
GE
$361B
$86.3M 0.08%
847,685
+534,757
+171% +$49.5M
MCD icon
302
PUT
McDonald's
MCD
$192B
$86.1M 0.08%
290,300
-2,200
-0.8% -$599K
CME icon
303
CME Group
CME
$98.9B
$85.7M 0.07%
407,021
-353,211
-46% -$75.4M
RIG icon
304
Transocean
RIG
$6.61B
$84.9M 0.07%
13,373,227
-8,923,346
-40% -$59.7M
CI icon
305
Cigna
CI
$73.3B
$84.8M 0.07%
283,287
+242,141
+588% +$70.8M
MDLZ icon
306
Mondelez International
MDLZ
$82.3B
$84.4M 0.07%
1,164,908
-590,602
-34% -$40.5M
MCD icon
307
McDonald's
MCD
$192B
$82.8M 0.07%
279,311
-550,155
-66% -$150M
CLX icon
308
Clorox
CLX
$12.9B
$82.2M 0.07%
576,386
-217,546
-27% -$29M
RRC icon
309
Range Resources
RRC
$9.59B
$82.1M 0.07%
2,698,647
-1,228,776
-31% -$40.3M
KO icon
310
Coca-Cola
KO
$392B
$81.7M 0.07%
1,385,963
-2,168,877
-61% -$123M
VEEV icon
311
Veeva Systems
VEEV
$40.3B
$80.2M 0.07%
+416,410
New +$78.5M
ETRN
312
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$79.9M 0.07%
7,847,239
+525,265
+7% +$4.94M
SLB icon
313
SLB Ltd
SLB
$79.9B
$79.5M 0.07%
1,527,409
+1,484,562
+3,465% +$80.7M
COF icon
314
Capital One
COF
$134B
$79.4M 0.07%
605,443
+116,491
+24% +$12.6M
HOOD icon
315
Robinhood
HOOD
$97.2B
$78.8M 0.07%
6,188,617
+1,809,364
+41% +$18M
CBOE icon
316
Cboe Global Markets
CBOE
$31.4B
$78.8M 0.07%
441,466
-328,399
-43% -$56.3M
RBLX icon
317
CALL
Roblox
RBLX
$27.4B
$78.5M 0.07%
1,717,300
+1,211,200
+239% +$44.8M
ASML icon
318
CALL
ASML
ASML
$677B
$78.3M 0.07%
103,500
+60,300
+140% +$39.8M
FWONK icon
319
Liberty Media Series C
FWONK
$26.3B
$78.3M 0.07%
1,240,237
+525,831
+74% +$34.4M
AOS icon
320
A.O. Smith
AOS
$8.57B
$77.8M 0.07%
943,757
-244,913
-21% -$18.1M
QCOM icon
321
CALL
Qualcomm
QCOM
$169B
$77.7M 0.07%
537,300
+68,500
+15% +$8.48M
GILD icon
322
Gilead Sciences
GILD
$181B
$77.5M 0.07%
956,641
-1,373,449
-59% -$107M
LEN icon
323
Lennar Class A
LEN
$21B
$77.4M 0.07%
536,177
-260,417
-33% -$31.4M
MAR icon
324
Marriott International
MAR
$92.9B
$77M 0.07%
341,663
+34,469
+11% +$6.99M
SNPS icon
325
Synopsys
SNPS
$76.2B
$76.9M 0.07%
149,311
-6,470
-4% -$3.31M

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.